RxDoctor Payments Data

Matthew Petznick, DO

Family Medicine · Sandusky, OHNPI 1841363447

Payments from drug & device makers

$756in general payments, 2019–2025

Across 46 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$164
  • Novo Nordisk$73
  • Dexcom, Inc.$66
  • Lilly USA, LLC$56
  • AstraZeneca$56
  • Takeda Pharmaceuticals U.S.A., Inc.$44
  • plus $297 from 14 others

What the payments were for

  • Food & beverage$756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$756 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$62,082
Medicare patients
184
Services billed
1,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$43,109
JardianceEmpagliflozin21$32,801
EliquisApixaban24$24,700
JanuviaSitagliptin Phosphate15$23,211
Emgality PenGalcanezumab-Gnlm16$15,647
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$11,587
Breo ElliptaFluticasone/Vilanterol11$7,548
Tresiba Flextouch U-100Insulin Degludec14$5,986
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$4,082
Atorvastatin Calcium338$3,591
SymbicortBudesonide/Formoterol Fumarate13$3,057
Olmesartan Medoxomil89$2,108
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide29$2,099
Esomeprazole Magnesium35$1,774
Pantoprazole Sodium115$1,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$73$43,10942 claims
Boehringer IngelheimJardiance$28$32,80121 claims
MerckJanuvia$23$23,21115 claims
AstraZenecaBreztri Aerosphere, Symbicort$56$14,64428 claims
GSKBreo Ellipta$26$7,54811 claims
AbbVieSynthroid$164$1,43730 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →